These webcasts and presentations contain "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things, future operating and financial performance, product development, regulatory approvals, market position, expenditures, impact of acquisitions and dispositions, business strategy and restructuring plans. These statements use words, and variations of words, such as "will," "plan," "expect," , "anticipate," "estimate," "next," "project," "potential," "continue," "expand" and "grow". You are cautioned not to rely on these forward-looking statements. These statements are based on current assumptions and expectations of future events at the time they are made and thus are inherently subject to uncertainty.

If underlying assumptions prove inaccurate, or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed in these forward-looking statements. Risks and uncertainties include, but are not limited to: economic and financial market factors, such as interest rate and currency exchange rate fluctuations; competition, including technological advances, new products and patents attained by competitors; challenges inherent in product development, including uncertainty of clinical success and obtaining regulatory approvals; challenges to patents; the impact of patent expirations; uncertainty of commercial success of new and existing products; significant adverse litigation or government action, including related to product liability claims; the ability of the company to successfully execute strategic plans including restructuring plans; the impact of business combinations and divestitures and the possibility that the expected benefits and opportunities of an acquisition are not realized in the anticipated time frame or at all; changes in behavior and spending patterns or financial distress of purchasers of health care products and services; changes to applicable laws and regulations, including tax laws and global health care reforms; trends toward health care cost containment; financial instability of international economies and legal systems and sovereign risk; manufacturing difficulties or delays, internally or within the supply chain; increased scrutiny of the health care industry by government agencies; product efficacy or safety concerns resulting in product recalls or regulatory action; and the potential failure to meet obligations in compliance agreements with government bodies.

A further list and description of these risks, uncertainties and other factors can be found in the company's most recently filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q, including in the sections captioned “Cautionary Note Regarding Forward-Looking Statements” and “Risk Factors,” and in the company's subsequent filings with the Securities and Exchange Commission. Copies of these filings are available online at www.sec.gov, on this Internet site (www.jnj.com) under “Investors—SEC Filings,” or on request from Johnson & Johnson. Information in each of these presentations is as of the dates and time periods indicated therein, and the company does not undertake to update any of the information contained in these materials. Accordingly, YOU SHOULD NOT RELY ON THE ACCURACY OF ANY OF THE STATEMENTS OR OTHER INFORMATION CONTAINED IN ANY ARCHIVED WEBCASTS OR ON DEMAND VIDEOS.

Webcasts on this website are the property of Johnson & Johnson. Any redistribution, retransmission or rebroadcast of this webcast in any form without the express written consent of Johnson & Johnson is strictly prohibited. Please see our Legal Notice for more information about the content of this website and copyright laws.

Webcasts & Presentations

Archived Events
Date Event Details
Jan 22, 2020 at 8:00 AM EST
Johnson & Johnson Fourth Quarter Earnings Call and Webcast UPDATED
Jan 13, 2020 at 5:30 PM EST
38th Annual JP Morgan Health Care Conference
Oct 18, 2019 at 11:30 AM EDT
Johnson & Johnson Investor Call on Voluntary Baby Powder Lot Recall
Oct 15, 2019 at 8:30 AM EDT
Q3 Note: Webcast and Podcast do not reflect results updated in accordance with the Form 8-K filed on October 23, 2019. Please visit quarterly results for more information
Sep 10, 2019 at 10:00 AM EDT
2019 Morgan Stanley 17th Annual Global Healthcare Conference
Sep 05, 2019 at 9:45 AM EDT
14th Annual Wells Fargo Securities Healthcare Conference
Sep 05, 2019 at 7:30 AM EDT
Barclays Global Consumer Staples Conference
Jul 16, 2019 at 8:30 AM EDT
Johnson & Johnson Second Quarter Earnings Call and Webcast
Jun 12, 2019 at 8:00 AM EDT
Health for Humanity Webcast
May 15, 2019 at 8:30 AM EDT
Pharmaceutical Business Review
Pharmaceutical Business Review
May 15, 2019
7:30 a.m. - 2:30 p.m.

The Hyatt Regency Hotel, New Brunswick, NJ

 
Time Topic Speaker Presentation Video
7:30 a.m. Registration/Continental Breakfast      
8:30 a.m. Introductions/Overview of Day Chris DelOrefice, Vice President, Investor Relations PDF Video
  Opening Remarks Alex Gorsky, Chairman and Chief Executive Officer PDF Video
  Pharmaceutical Business Overview Jennifer Taubert, Executive Vice President, Worldwide Chairman, Pharmaceuticals PDF Video
  Pharmaceutical R&D Strategy Mathai Mammen, M.D., Ph.D., Global Head Janssen Research and Development PDF Video
9:50 a.m. Break      
10:15 a.m. Immunology David Lee, M.D., Ph.D., Global Therapeutic Area Head, Immunology PDF Video
10:30 a.m. Infectious Diseases and Vaccines Johan Van Hoof, M.D., Global Therapeutic Area Head, Vaccines
James Merson, Ph.D., Global Therapeutic Area Head, Infectious Diseases
PDF Video
  Neuroscience,
SPRAVATO Video and Conversation
Husseini K. Manji, M.D., F.R.C.P.C., Global Therapeutic Area Head, Neuroscience PDF Video
  Therapeutic Area Q&A Panel R&D Presenters: Immunology, Infectious Diseases and Vaccines, Neuroscience
Vanessa Broadhurst, Company Group Chairman, Global Commercial Strategy Organization
Scott White, Company Group Chairman, North America Pharmaceuticals
  Video
11:45 p.m. Lunch      
12:15 p.m. Pulmonary Hypertension Martin Fitchet, M.D., Global Therapeutic Area Head, Pulmonary Hypertension PDF Video
  Cardiovascular/Metabolism James F. List, M.D., Ph.D., Global Therapeutic Area Head, Cardiovascular & Metabolism PDF Video
  Oncology Peter F. Lebowitz, M.D., Ph.D., Global Therapeutic Area Head, Oncology PDF Video
  Therapeutic Area Q&A Panel R&D Presenters: Pulmonary Hypertension, Cardiovascular/Metabolism, Oncology
Vanessa Broadhurst, Company Group Chairman, Global Commercial Strategy Organization
Scott White, Company Group Chairman, North America Pharmaceuticals
  Video
1:45 p.m. Break      
  Financial Overview Joseph J. Wolk, Executive Vice President, Chief Financial Officer PDF Video
2:00 p.m. Enterprise/Strategic Q&A Panel Alex Gorsky, Chairman and Chief Executive Officer
Joaquin Duato, Vice Chairman of the Executive Committee
Paul Stoffels, Vice Chairman of the Executive Committee & Chief Scientific Officer
Jennifer Taubert, Executive Vice President, Worldwide Chairman, Pharmaceuticals
Joseph J. Wolk, Executive Vice President, Chief Financial Officer
Mathai Mammen, M.D., Ph.D., Global Head Janssen Research and Development
  Video
2:30 p.m. Closing     Video
Apr 25, 2019 at 10:00 AM EDT
Johnson & Johnson 2019 Annual Meeting of Shareholders
Apr 16, 2019 at 8:30 AM EDT
Johnson & Johnson First Quarter Earnings Call and Webcast
Mar 14, 2019 at 10:15 AM EDT
Barclays Global Healthcare Conference 2019
Feb 28, 2019 at 11:00 AM EST
Leerink Global Healthcare Conference

Cautionary Statement                         

These webcasts and presentations contain "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things, future operating and financial performance, product development, regulatory approvals, market position, expenditures, impact of acquisitions and dispositions, business strategy and restructuring plans. These statements use words, and variations of words, such as "will," "plan," "expect," , "anticipate," "estimate," "next," "project," "potential," "continue," "expand" and "grow". You are cautioned not to rely on these forward-looking statements. These statements are based on current assumptions and expectations of future events at the time they are made and thus are inherently subject to uncertainty.

If underlying assumptions prove inaccurate, or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed in these forward-looking statements. Risks and uncertainties include, but are not limited to: economic and financial market factors, such as interest rate and currency exchange rate fluctuations; competition, including technological advances, new products and patents attained by competitors; challenges inherent in product development, including uncertainty of clinical success and obtaining regulatory approvals; challenges to patents; the impact of patent expirations; uncertainty of commercial success of new and existing products; significant adverse litigation or government action, including related to product liability claims; the ability of the company to successfully execute strategic plans including restructuring plans; the impact of business combinations and divestitures and the possibility that the expected benefits and opportunities of an acquisition are not realized in the anticipated time frame or at all; changes in behavior and spending patterns or financial distress of purchasers of health care products and services; changes to applicable laws and regulations, including tax laws and global health care reforms; trends toward health care cost containment; financial instability of international economies and legal systems and sovereign risk; manufacturing difficulties or delays, internally or within the supply chain; increased scrutiny of the health care industry by government agencies; product efficacy or safety concerns resulting in product recalls or regulatory action; and the potential failure to meet obligations in compliance agreements with government bodies.

A further list and description of these risks, uncertainties and other factors can be found in the company's most recently filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q, including in the sections captioned “Cautionary Note Regarding Forward-Looking Statements” and “Risk Factors,” and in the company's subsequent filings with the Securities and Exchange Commission. Copies of these filings are available online at www.sec.gov, on this Internet site (www.jnj.com) under “Investors—SEC Filings,” or on request from Johnson & Johnson. Information in each of these presentations is as of the dates and time periods indicated therein, and the company does not undertake to update any of the information contained in these materials. Accordingly, YOU SHOULD NOT RELY ON THE ACCURACY OF ANY OF THE STATEMENTS OR OTHER INFORMATION CONTAINED IN ANY ARCHIVED WEBCASTS OR ON DEMAND VIDEOS.

Webcasts on this website are the property of Johnson & Johnson. Any redistribution, retransmission or rebroadcast of this webcast in any form without the express written consent of Johnson & Johnson is strictly prohibited. Please see our Legal Notice for more information about the content of this website and copyright laws.

This site uses cookies as described in our Cookie Policy Please click the "Accept" button or continue to use our site if you agree to our use of cookies.